These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5486564)

  • 21. The Australia antigen and blood transfusion.
    Gocke DJ
    Vox Sang; 1970; 19(3):327-31. PubMed ID: 4993784
    [No Abstract]   [Full Text] [Related]  

  • 22. [Australia antigen and Australia antibody carriers in healthy populations].
    Frey-Wettstein M
    Schweiz Med Wochenschr; 1972 Apr; 102(15):534-40. PubMed ID: 5019772
    [No Abstract]   [Full Text] [Related]  

  • 23. The determination of Australia antigen and antibody by cross-over immunoelectrophoresis.
    Pongpipat D; Suvatte V; Ratanawong A
    J Med Assoc Thai; 1971 Aug; 54(8):569-74. PubMed ID: 5158774
    [No Abstract]   [Full Text] [Related]  

  • 24. [Australia (SH)-antigen in blood donors and recipients].
    Sanwald R; Sauerbruch T
    Dtsch Med Wochenschr; 1970 Oct; 95(43):2153-6. PubMed ID: 5477957
    [No Abstract]   [Full Text] [Related]  

  • 25. Methods for validation of hepatitis B virus inactivation.
    Gerlich WH; Glebe D
    Dev Biol (Basel); 2004; 118():113-22. PubMed ID: 15645680
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis-associated antigen in blood donors in Kenya.
    Parker AM; Muiruri KL; Preston JK
    East Afr Med J; 1971 Sep; 48(9):470-5. PubMed ID: 5144565
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
    Allain JP; Sarkodie F; Candotti D; Opare-Sem O
    Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of vancomycin on platelets, plasma proteins and hepatitis B surface antigen.
    Coller BS; Lundberg WB; Gralnick HR
    Thromb Diath Haemorrh; 1975 Sep; 34(1):83-93. PubMed ID: 1188837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Au-SH-antigen and blood transfusion].
    Fröhlich C
    Hippokrates; 1971 Mar; 42(1):118-20. PubMed ID: 5550575
    [No Abstract]   [Full Text] [Related]  

  • 32. [Investigation of hepatitis B virus infection in blood donors].
    Wang D; Liu C; Shen Y; Tan D
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):540-2. PubMed ID: 10806762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Chevrier MC; St-Louis M; Perreault J; Caron B; Castilloux C; Laroche J; Delage G
    Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of hepatitis B virus (HBV) markers in blood donors of 13 Western Hemisphere countries: proceedings of the Red Cross Latin American hepatitis B workshop.
    Mazzur S; Nath N; Fang C; Bastiaans MJ; Molinaris JL; Balcaser M; Beker S; Brunings EA; Cameron AR; Farrell V; Fay OH; Labrador-González G; González G; Gutiérrez A; Jaramillo C; Katz R; Leme López MB; Levy-Koenig E; Morales Ayala F; Rodríguez Amaya J; Rodríguez-Moyado H; de Torres RA; Velasco M
    Bull Pan Am Health Organ; 1980; 14(1):44-51. PubMed ID: 7378625
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidence of the Australia antigen in various diseases.
    Bonomo L; Dammacco F; Schena FP; Miglietta A; Scarano NP
    Folia Allergol (Roma); 1970; 17(6):517-23. PubMed ID: 4996030
    [No Abstract]   [Full Text] [Related]  

  • 37. [Present status of Australian antigen determination in blood transfusion services].
    Spielmann W; Seidl S
    Dtsch Med Wochenschr; 1971 Oct; 96(41):1588-94. PubMed ID: 4999757
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of donors and blood products reactive for hepatitis B virus DNA.
    Reesink HW; Allain JP
    Vox Sang; 2006 Nov; 91(4):281. PubMed ID: 17105601
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on Australia antigen in serums of blood donors].
    Blauărmel O; Surber H; Matthes H; Wagner K; Schneider G
    Dtsch Gesundheitsw; 1971 Oct; 26(43):2009-10. PubMed ID: 5144071
    [No Abstract]   [Full Text] [Related]  

  • 40. Effectiveness of various minipool nucleic acid test systems for hepatitis B virus detection in blood donors.
    Grabarczyk P; Letowska M; Kopacz A; Liszewski G; Sulkowska E; Brojer E
    Transfusion; 2009 Jul; 49(7):1494-5. PubMed ID: 19602212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.